已收录 270281 条政策
 政策提纲
  • 暂无提纲
L-Selenocystine induce HepG2 cells apoptosis through ROS-mediated signaling pathways
[摘要] At present, Hepatocarcinoma is one of the main causes of tumor related death all over the world. However, there are still many clinical restrictions on the treatment of liver cancer. Recently, L-Selenocystine has been shown to be a novel treatment for tumors, especially human glioma cells. But, the mechanism of L-Selenocystine against hepatocellular carcinoma remains unclear. Therefore, the main objective of this study was to investigate the effects of L-Selenocystine on HepG2 cell proliferation and activation of reactive oxygen species (ROS) mediated signaling pathway. L-Selenocystine can significantly inhibit HepG2 cell proliferation by activating caspase-3 and cleaving PARP to induce apoptosis. Moreover, the excessive production of ROS and the influence of Bax signaling pathway which can promote cell apoptosis are key factors for L-Selenocystine to induce HepG2 cell apoptosis. Therefore, the date of this study suggest that ROS mediated signal transduction mechanism may provide certain reference significance for L-Selenocystine induced HepG2 cell apoptosis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 仪器
[关键词] Selenium;Apoptosis;L-Selenocystine;Anticancer activity;ROS [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文